Success Metrics

Clinical Success Rate
100.0%

Based on 15 completed trials

Completion Rate
100%(15/15)
Active Trials
2(10%)
Results Posted
33%(5 trials)

Phase Distribution

Ph phase_2
4
19%
Ph not_applicable
12
57%
Ph phase_3
2
10%
Ph phase_4
1
5%
Ph phase_1
2
10%

Phase Distribution

2

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution21 total trials
Phase 1Safety & dosage
2(9.5%)
Phase 2Efficacy & side effects
4(19.0%)
Phase 3Large-scale testing
2(9.5%)
Phase 4Post-market surveillance
1(4.8%)
N/ANon-phased studies
12(57.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.8%

15 of 16 finished

Non-Completion Rate

6.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

21

all time

Status Distribution
Active(2)
Completed(15)
Terminated(1)
Other(3)

Detailed Status

Completed15
unknown2
Recruiting2
Withdrawn1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (9.5%)
Phase 24 (19.0%)
Phase 32 (9.5%)
Phase 41 (4.8%)
N/A12 (57.1%)

Trials by Status

withdrawn15%
unknown210%
recruiting210%
completed1571%
suspended15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT07514663Not Applicable

Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile

Recruiting
NCT05404230Not Applicable

Prevention of Oxaliplatin-induced Nerve Damage in the Body's Extremities

Recruiting
NCT06061510Not Applicable

Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus

Completed
NCT06129526Phase 4

Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes

Unknown
NCT01841944Not Applicable

Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction

Completed
NCT03280615Phase 3

Omega 3 Fatty Acids in Patients With Chronic Renal Disease

Completed
NCT01145066Phase 2

Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects

Completed
NCT03202654Not Applicable

Effects of Corn and Coconut Oils on Lipoprotein Lipids, Insulin Sensitivity and Inflammation

Completed
NCT00962598Phase 2

The Role Of Omega-3 Fatty Acids In Adolescent Depression

Completed
NCT00312897Phase 2

Omega-3 Fatty Acids in Adolescent Depression

Completed
NCT00806442Phase 1

Treatment of Bronchial Asthma With Borage and Echium Seed Oils

Completed
NCT01191177Phase 1

Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease

Withdrawn
NCT02346994Not Applicable

Development of Melt Organic Baking Fat for Reducing Child Obesity

Completed
NCT02625870Phase 3

Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides

Unknown
NCT01308957Not Applicable

Fish Oil and Muscle Function

Completed
NCT01744275Phase 2

HOPE-Epilepsy Trial

Suspended
NCT01925716Not Applicable

Effects of The Effects of Dietary Oils on Fasting Lipoprotein Lipids

Completed
NCT00891826Not Applicable

Omega-3 Fatty Acids in Bipolar Patients With a Low Omega-3 Index and Reduced Heart Rate Variability

Completed
NCT01806142Not Applicable

Effects of Medium-Chain Triglycerides on Chylomicron Secretion and Expression of Genes That Regulate Intestinal Lipid Metabolism in Men With Dyslipidemia Associated With the Metabolic Syndrome

Completed
NCT01634776Not Applicable

Behavioral, Genetic, and Epigenetic Implications of Dietary Supplementation With Alpha-linolenic Acid in Humans

Completed

Drug Details

Intervention Type
OTHER
Total Trials
21